Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-041 - A phase II trial of erlotinib for previously treated Japanese patients with advanced non-small cell lung cancer harboring EGFR mutations: results of the Central Japan Lung Study Group trial (CJLSG0904).

      09:30 - 09:30  |  Author(s): T. Hase

      • Abstract

      Loading...

  • +

    MO03 - Thymic Malignancies

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 11
    • Moderators:F. Detterbeck
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Gallery B, Level 1
    • +

      MO03.02 - Surgical Outcome of Patients with Stage III Thymoma in the Japanese Nationwide Database

      10:35 - 10:40  |  Author(s): Y. Yamada

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-012 - Phase Ia/Ib study of the anti-MET antibody onartuzumab (MetMAb) in patients with solid tumors or MET-positive lung cancer

      09:30 - 09:30  |  Author(s): H. Horinouchi

      • Abstract

      Loading...

    • +

      P2.11-025 - Erlotinib versus Radiation Therapy for Brain Metastases in Patients with EGFR-Mutant Lung Adenocarcinoma

      09:30 - 09:30  |  Author(s): N.K. Gerber

      • Abstract

      Loading...

  • +

    O14 - Radiotherapy - Toxicity and Clinical Trials

    • Type: Oral Abstract Session
    • Track: Radiation Oncology + Radiotherapy
    • Presentations: 8
    • Moderators:G. Pratt
    • Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
    • +

      O14.03 - Using generalized equivalent uniform dose (gEUD) to model volume effects for brachial plexopathy after high-dose stereotactic body radiation therapy (SBRT)

      10:50 - 11:00  |  Author(s): S.U. Din

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.10 - Poster Session 3 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 55
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.10-024 - Phase II study of Pemetrexed + Carboplatin + Bevacizumab as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation: CENTRAL JAPAN LUNG STUDY GROUP (CJLSG) 0910 TRIAL

      09:30 - 09:30  |  Author(s): T. Kimura

      • Abstract

      Loading...